Specifically, we demonstrated that the ability of CCN1 to drive breast tumor initiation, vascularization, and invasiveness, as well as to provide protection of breast cancer cells against chemotherapy-induced apoptosis, was largely mediated through binding to integrin αvβ3, whose expression is also induced by CCN1 [30, 34, 35]. The gene discussed is CCN1; the disease is breast cancer.